Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Surgery|August 21, 2023
Differences in the surgical management of early-stage hepatocellular carcinoma at minority versus non-minority-serving hospitalsMohamedraed Elshami, Lauryn Bailey, Richard S Hoehn, et al.
JCO Precision Oncology|June 30, 2022
Tumor Mutational Burden Is a Potential Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Advanced Biliary Tract CancerSavannah S Liddell, Sakti Chakrabarti, Grant A Wintheiser, et al.
BMJ Open|May 31, 2022
BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumoursPashtoon Murtaza Kasi, Sakti Chakrabarti, Sarah Sawyer, et al.
JCO Precision Oncology|July 6, 2023
Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor EffectivenessJulia C F Quintanilha, Michael H Storandt, Ryon P Graf, et al.
Annals of Surgical Oncology|March 19, 2024
Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysisKavin Sugumar, Henry Stitzel, Victoria Wu, et al.
Oncology Reviews|January 30, 2026
Surgical cytoreduction versus systemic therapy in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms (GEP-NENS): a national cancer database analysis (NCDB)Amr Mohamed, Fasih A Ahmed, Omkar Pawar, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2020
Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trialsFrank A Sinicrope, Sakti Chakrabarti, Pierre Laurent-Puig, et al.
Annals of Surgery|April 18, 2023
Why the Treatment Sequence Matters: Interplay Between Chemotherapy Cycles Received, Cumulative Dose Intensity, and Survival in Resected Early-stage Pancreas CancerVictoria S Wu, Mohamedraed Elshami, Henry J Stitzel, et al.
The Oncologist|December 13, 2019
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract CarcinomaSakti Chakrabarti, Tyler J Zemla, Daniel H Ahn, et al.
Cancer Medicine|December 23, 2023
Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapySaryleine de Ortiz de Choudens, Alexis Visotcky, Anjishnu Banerjee, et al.
Pageof 6